The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen. [PDF]
Breast Cancer Res TreatSafgren SL +15 more
europepmc +1 more source
Pharmaco- and therapygenetic aspects in the treatment of anxiety disorders beyond the serotonergic system: a brief review [PDF]
, 2012 Bagdy, György +3 more
core
ADME of Bromo-DragonFLY as an example of a new psychoactive substance (NPS) - application of in Silico methods for prediction: absorption, distribution, metabolism and excretion. [PDF]
Sci RepNoga M, Jurowski K.
europepmc +1 more source
Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort. [PDF]
Clin Transl SciMoore C +8 more
europepmc +1 more source
Der Einfluss des Body-Mass-Index auf die Pharmakokinetik von Methadon [PDF]
, 2009 Wicht, Albert
core
A Comprehensive CYP2D6 Drug-Drug-Gene Interaction Network for Application in Precision Dosing and Drug Development. [PDF]
Clin Pharmacol TherRüdesheim S +14 more
europepmc +1 more source
A systematic review of real-world evidence on the clinical relevance, characterization, and utility of <i>CYP2D6</i> biomarker testing. [PDF]
J Pharm Pharm SciRodriguez P +4 more
europepmc +1 more source
In vitro comparative analysis of metabolic capabilities and inhibitory profiles of selected CYP2D6 alleles on tramadol metabolism. [PDF]
Clin Transl SciNahid NA +4 more
europepmc +1 more source
CYP2D6 genotype and outcome in tamoxifen treated early breast cancer. [PDF]
Acta OncolThorén L +6 more
europepmc +1 more source
The Influence of Genetic Polymorphisms in Cytochrome P450 (CYP1A1 and 2D6) Gene on the Susceptibility to Philadelphia Negative Chronic Myeloid Leukemia in Sudanese Patients. [PDF]
Int J Mol SciElderdery AY +9 more
europepmc +1 more source